Comparative net cost impact of the utilization of romiplostim and intravenous immunoglobulin for the treatment of patients with immune thrombocytopenia in Québec, Canada

Title
Comparative net cost impact of the utilization of romiplostim and intravenous immunoglobulin for the treatment of patients with immune thrombocytopenia in Québec, Canada
Authors
Keywords
-
Journal
JOURNAL OF MEDICAL ECONOMICS
Volume 16, Issue 2, Pages 318-326
Publisher
Informa Healthcare
Online
2012-12-06
DOI
10.3111/13696998.2012.756400

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation